What's new? Log in Free sign up

Jaguar Health (JAGX) News and press releases

Company Profile

News

From Benzinga Pro

Stocks That Hit 52-Week Lows On Monday

On Monday, 198 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

Thursday's session saw 337 companies set new 52-week lows.

Jaguar Health Leveraging AI To Support Patient Access To Mytesi, The Company's FDA-Approved Prescription Drug

Biotech, News, General

AI technology is expected to help make it faster and easier for Mytesi® patients to start and stay on the drug SAN FRANCISCO, CA / ACCESSWIRE / March 13, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX)

Here Are The Year's Highest Priced Psychedelics Stocks In US Markets

Cannabis, Earnings, News, Penny Stocks, Psychedelics, Small Cap, Events, Markets

After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.

FDA Grants Orphan Drug Designation To Jaguar Health For Crofelemer For Microvillus Inclusion Disease, A Second Rare Disease Indication In The U.S.

Biotech, News, FDA, General

Crofelemer was previously granted Orphan Drug Designation by the FDA for short bowel syndrome SAN FRANCISCO, CA / ACCESSWIRE / February 28, 2023 / Jaguar Health (NASDAQ:JAGX) ("Jaguar" or the

Jaguar Health Subsidiary Napo Pharmaceuticals Inc. Gets FDA Orphan Drug Designation For Crofelemer For Treatment Of Microvillus Inclusion Disease

Biotech, News, FDA, General

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=897722

BioRxiv Journal Article Out On Jaguar Health's Drug Titled "Effects Of Orally Administered Crofelemer On The Incidence And Severity Of Neratinib-Induced Diarrhea In Female Dogs"

Biotech, News, General

https://www.biorxiv.org/content/10.1101/2023.02.23.529666v1

Jaguar Health Receives Notice Of Allowance For U.S. Patent For Lead FDA Approved Drug Crofelemer

Biotech, News, FDA, General

Company's IP estate includes approximately 200 patents issued and pending SAN FRANCISCO, CA / ACCESSWIRE / February 23, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the

Jaguar Health Provides Updates Regarding Company's Focus On Rare And Orphan Disease Indications In The U.S. & Europe

Biotech, News, FDA, Global, General

Rare disease indications are the sole focus of Napo Therapeutics, the corporation established by Jaguar in Italy in 2021, with an initial focus on short bowel syndrome Jaguar to take the lead on microvillus inclusion

Jaguar Health Receives Notice Of Allowance For U.S. Patent Application Titled 'METHODS AND COMPOSITIONS FOR TREATING BILE ACID DIARRHEA, DIARRHEA ASSOCIATED WITH SMALL INTESTINE RESECTION OR GALLBLADDER REMOVAL, AND SHORT BOWEL SYNDROME'

https://patentcenter.uspto.gov/applications/16617466/ifw/docs

Here's Why Jaguar Health (JAGX) Stock Is Volatile Tuesday

Jaguar Health Inc (NASDAQ: JAGX) shares are trading lower by some 7.73% to $5.01 going into the close of Tuesday's session.

Nasdaq Rises 1.5%; Pliant Therapeutics Shares Spike Higher

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 150 points on Monday. The Dow traded up 0.46% to 33,527.51 while the NASDAQ rose 1.55% to 11,313.03. The S&P 500 also rose, gaining, 0.85% to 4,006.43.

Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.

12 Health Care Stocks Moving In Monday's Intraday Session

Dow Jumps Over 300 Points; Crude Oil Up 1%

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 30 points on Monday. The Dow traded up 0.94% to 33,687.69 while the NASDAQ rose 1.93% to 11,355.16. The S&P 500 also rose, gaining, 1.31% to 4,024.60.

US Stocks Mostly Higher; Synchrony Financial Earnings Top Views

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 90 points on Monday.

Jaguar Health Announces Establishment Of Board Of Directors For Newly Formed Joint Venture Magdalena Biosciences

Magdalena Biosciences is focused on developing novel, natural prescription medicines derived from plants for mental health indications including attention-deficit/hyperactivity disorder (ADHD) in adults SAN FRANCISCO,

12 Health Care Stocks Moving In Monday's Pre-Market Session

Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity contract by the U.S. Air Force.

12 Health Care Stocks Moving In Thursday's Intraday Session

Press releases

From Benzinga Pro

Jaguar Health Celebrates U.N. International Day of Forests with Milestone of Providing Income to 20,000+ People Living in Tropical Rainforest Communities

News, Press Releases

The United Nations General Assembly's theme for the 2023 International Day of Forests is "Forests and Health" as Jaguar collaborates with communities in the Amazonia rainforest to ethically source the active

Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company's FDA-Approved Prescription Drug

News, Press Releases

AI technology is expected to help make it faster and easier for Mytesi® patients to start and stay on the drugSAN FRANCISCO, CA / ACCESSWIRE / March 13, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar"

Jaguar Health to Present at BioTrinity 2023 Conference's R&D Spotlight on Rare Diseases

Events, Press Releases

Presentation will cover Jaguar and Napo Therapeutics' focus on development and commercialization of crofelemer for short bowel syndrome (SBS) and congenital diarrheal disorders (CDD)Crofelemer has received orphan drug

FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US

News, Press Releases

Crofelemer was previously granted Orphan Drug Designation by the FDA for short bowel syndromeSAN FRANCISCO, CA / ACCESSWIRE / February 28, 2023 / Jaguar Health (NASDAQ:JAGX) ("Jaguar" or the

Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer

News, Press Releases

Company's IP estate includes approximately 200 patents issued and pendingSAN FRANCISCO, CA / ACCESSWIRE / February 23, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today

Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea

News, Press Releases

Addition of OnTarget trial sites in Europe, South America and Asia has significantly accelerated enrollment, which is expected to complete in Q2 2023Adoption of premier digital health technology for data collection

Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.

Offerings, Press Releases

This closing on funds from SPRIM Global Investments, a healthcare-focused international venture capital firm, was completed at a fully diluted valuation of approximately €55 millionJaguar currently owns

Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement

News, Press Releases

JAGX's securities continue to be listed on NasdaqSAN FRANCISCO, CA / ACCESSWIRE / February 8, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that on February 7,

Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar's 2023 Focus on Human Drug Development

News, Press Releases

Tao Wang, SynWorld's General Manager and a long-term shareholder of restricted Jaguar stock, fully aligned on termination decisionSAN FRANCISCO, CA / ACCESSWIRE / February 1, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX)

Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling

News, Press Releases

SAN FRANCISCO, CA / ACCESSWIRE / February 1, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that it has entered into a service agreement with Shareholder

Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise

News, Press Releases

SAN FRANCISCO, CA / ACCESSWIRE / January 30, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that it has entered into a consulting agreement with Andrew Mulberg, M.D. to enhance the company's regulatory

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

News, Press Releases

SAN FRANCISCO, CA / ACCESSWIRE / January 27, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective January 19, 2023, the Company granted 7,500 restricted

Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe

News, Press Releases

Rare disease indications are the sole focus of Napo Therapeutics, the corporation established by Jaguar in Italy in 2021, with an initial focus on short bowel syndromeJaguar to take the lead on microvillus inclusion

Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer

News, Press Releases

Milestone supports the expansion of manufacturing volume required for potential additional indications for crofelemer, including cancer therapy-related diarrheaCrofelemer API (active pharmaceutical ingredient)

Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences

Contracts, Press Releases

Magdalena Biosciences is focused on developing novel, natural prescription medicines derived from plants for mental health indications including attention-deficit/hyperactivity disorder (ADHD) in adultsSAN FRANCISCO, CA

Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders

News, Press Releases

All proposals approvedCompany announces 1-for-75 reverse stock split to support compliance with Nasdaq listing standardsShares of Jaguar Health common stock to begin trading on split-adjusted basis on January 23,

Thinking about buying stock in Salarius Pharmaceuticals, Appharvest, Ally Financial, Jaguar Health, or IONQ?

Opinion, Press Releases

NEW YORK, Jan. 20, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SLRX, APPH, ALLY, JAGX, and IONQ.

Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st

Events, Press Releases

SAN FRANCISCO, CA / ACCESSWIRE / January 20, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that on Tuesday, January 31, 2023 Lisa Conte, Jaguar's president,

REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar's Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Derived from Psychoactive Plants

News, Press Releases

The webcast will include:Commentary from leading breast cancer medical oncologist and hematologist Lee Schwartzberg, MD, FACP on the unmet need for a focused and biological approach to the management of cancer

Thinking about buying stock in Jaguar Health, Avaya, Marathon Digital, Lucid, or Tonix Pharmaceuticals?

Small Cap, Opinion, Press Releases

NEW YORK, Jan. 11, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, AVYA, MARA, LCID, and TNXP.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.